Kakkis ED - Search Results

1

Enzyme replacement therapy in feline mucopolysaccharidosis I.

Kakkis ED, Schuchman E, He X, Wan Q, Kania S, Wiemelt S, Hasson CW, O'Malley T, Weil MA, Aguirre GA, Brown DE, Haskins ME. Kakkis ED, et al. Mol Genet Metab. 2001 Mar;72(3):199-208. doi: 10.1006/mgme.2000.3140. Mol Genet Metab. 2001. PMID: 11243725

2

Long-term and high-dose trials of enzyme replacement therapy in the canine model of mucopolysaccharidosis I.

Kakkis ED, McEntee MF, Schmidtchen A, Neufeld EF, Ward DA, Gompf RE, Kania S, Bedolla C, Chien SL, Shull RM. Kakkis ED, et al. Biochem Mol Med. 1996 Aug;58(2):156-67. doi: 10.1006/bmme.1996.0044. Biochem Mol Med. 1996. PMID: 8812735

3

Intrathecal enzyme replacement therapy: successful treatment of brain disease via the cerebrospinal fluid.

Dickson P, McEntee M, Vogler C, Le S, Levy B, Peinovich M, Hanson S, Passage M, Kakkis E. Dickson P, et al. Mol Genet Metab. 2007 May;91(1):61-8. doi: 10.1016/j.ymgme.2006.12.012. Epub 2007 Feb 26. Mol Genet Metab. 2007. PMID: 17321776 Free PMC article.

4

A follow-up study of MPS I patients treated with laronidase enzyme replacement therapy for 6 years.

Sifuentes M, Doroshow R, Hoft R, Mason G, Walot I, Diament M, Okazaki S, Huff K, Cox GF, Swiedler SJ, Kakkis ED. Sifuentes M, et al. Among authors: kakkis ed. Mol Genet Metab. 2007 Feb;90(2):171-80. doi: 10.1016/j.ymgme.2006.08.007. Epub 2006 Sep 29. Mol Genet Metab. 2007. PMID: 17011223

5

Intrathecal enzyme replacement therapy reduces lysosomal storage in the brain and meninges of the canine model of MPS I.

Kakkis E, McEntee M, Vogler C, Le S, Levy B, Belichenko P, Mobley W, Dickson P, Hanson S, Passage M. Kakkis E, et al. Mol Genet Metab. 2004 Sep-Oct;83(1-2):163-74. doi: 10.1016/j.ymgme.2004.07.003. Mol Genet Metab. 2004. PMID: 15464431

6

Enzyme replacement in a canine model of Hurler syndrome.

Shull RM, Kakkis ED, McEntee MF, Kania SA, Jonas AJ, Neufeld EF. Shull RM, et al. Among authors: kakkis ed. Proc Natl Acad Sci U S A. 1994 Dec 20;91(26):12937-41. doi: 10.1073/pnas.91.26.12937. Proc Natl Acad Sci U S A. 1994. PMID: 7809150 Free PMC article.

7

Vestronidase alfa: Recombinant human β-glucuronidase as an enzyme replacement therapy for MPS VII.

Cadaoas J, Boyle G, Jungles S, Cullen S, Vellard M, Grubb JH, Jurecka A, Sly W, Kakkis E. Cadaoas J, et al. Mol Genet Metab. 2020 May;130(1):65-76. doi: 10.1016/j.ymgme.2020.02.009. Epub 2020 Mar 6. Mol Genet Metab. 2020. PMID: 32192868 Free article. Clinical Trial.

8

Enzyme-replacement therapy in mucopolysaccharidosis I.

Kakkis ED, Muenzer J, Tiller GE, Waber L, Belmont J, Passage M, Izykowski B, Phillips J, Doroshow R, Walot I, Hoft R, Neufeld EF. Kakkis ED, et al. N Engl J Med. 2001 Jan 18;344(3):182-8. doi: 10.1056/NEJM200101183440304. N Engl J Med. 2001. PMID: 11172140 Free article. Clinical Trial.

9

Enzyme replacement therapy for the mucopolysaccharide storage disorders.

Kakkis ED. Kakkis ED. Expert Opin Investig Drugs. 2002 May;11(5):675-85. doi: 10.1517/13543784.11.5.675. Expert Opin Investig Drugs. 2002. PMID: 11996648 Review.

10

Immune tolerance improves the efficacy of enzyme replacement therapy in canine mucopolysaccharidosis I.

Dickson P, Peinovich M, McEntee M, Lester T, Le S, Krieger A, Manuel H, Jabagat C, Passage M, Kakkis ED. Dickson P, et al. Among authors: kakkis ed. J Clin Invest. 2008 Aug;118(8):2868-76. doi: 10.1172/JCI34676. J Clin Invest. 2008. PMID: 18654665 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

69 results

Search Page

Filters